Abstract 036: Proteomic Profiles of the Plant-based Diets and Cardiometabolic Disease Risk
Abstract
Background: Plant-based diets are recommended to lower the risk of type 2 diabetes (T2D) and coronary heart disease (CHD). Proteomic responses to plant-based diets may reveal biological pathways underlying the associations between plant-based diets and cardiometabolic disease risk. Hypothesis: Proteomic profiles reflecting adherence and biological response to an overall plant-based diet index (PDI) and a healthy PDI (hPDI) will associate with lower risks of T2D and CHD, but to an unhealthy PDI (uPDI) will associate with higher risks. Methods: We analyzed baseline plasma Olink antibody-based proteomic profiling and food frequency questionnaire (FFQ) data from 1,660 participants in the Nurses’ Health Study (NHS), NHSII, and Health Professional Follow-up Study. First, proteome-wide association analyses were conducted among 532 proteins for each PDI, adjusting for demographics, lifestyle, and BMI. For proteins with p <0.05, we applied elastic net regression with 10-fold cross-validation to develop plasma proteomic profiles related to baseline self-reported PDIs in a training set (n=1,162). We validated these profiles in a testing set (n=498). Multivariable Cox regression models examined associations between proteomic profiles of PDIs and incident T2D and CHD, adjusting for respective FFQ-derived PDI scores and many potential confounders. Results: We documented 173 T2D cases and 85 CHD cases during median follow-up periods of 23 and 24 years. We identified proteomic profiles comprised of 35, 54, and 40 proteins that correlated with (Spearman r) the FFQ-derived PDI (0.23), hPDI (0.29), and uPDI (0.23) scores, respectively. Each SD increment in the proteomic profiles of the PDI and hPDI was associated with a lower incident T2D risk (PDI: HR=0.59 [0.50, 0.69]; hPDI: HR=0.75 [0.64, 0.88]), whereas the proteomic profile of the uPDI was associated with a higher incident T2D risk (HR=1.37 [1.17, 1.60]). Each SD increment in the PDI proteomic profile, but not the hPDI proteomic profile, was associated with a lower incident CHD risk (HR=0.76 [0.60, 0.96]), whereas the uPDI proteomic profile was associated with a higher incident CHD risk (HR=1.28 [1.02, 1.60]). All the associations remained statistically significant after further adjustment for BMI, except for the association between the hPDI proteomic profile and T2D risk (HR=0.87 [0.73, 1.03]). Conclusions: Proteomic profiles of PDIs were associated with risks of T2D and CHD, independent of self-reported diet measures.
Article Details
Authors (16)
Qianyan Zheng
Dana Farber Cancer Institute, Newton, Massachusetts, United States
Zicheng Wang
Department of Human Genetics, The University of Chicago, Chicago, IL, USA.
Marta Guasch
UNIVERSITY OF COPENHAGEN, Copenhagen, Denmark
Fenglei Wang
JoAnn Manson
Brigham andWomen’s Hospital, Boston, MA, USA.
Lu Qi
Shandong Provincial Key Laboratory for Science of Material Creation and Energy Conversion, Science Center for Material Creation and Energy Conversion, Institute of Frontier Chemistry, School of Chemistry and Chemical Engineering
Qi Sun
Liming Liang
Zsu-Zsu Chen
Beth Israel Lahey Health, Boston, Massachusetts, United States
Robert Gerszten
Meir Stampfer
CHANNING DIV NETWORK MEDICINE, Boston, Massachusetts, United States
Walter Willett
Harvard university, Cambridge, Massachusetts, United States
Frank Hu
HARVARD SCHOOL OF PUBLIC HEALTH, Boston, Massachusetts, United States
A Heather Eliassen
Harvard Medical School, Boston, Massachusetts, United States
Danielle Haslam
Brigham and Womens Hospital, Canton, Massachusetts, United States
Shilpa Bhupathiraju
CHANNING DIV NETWORK MEDICINE, Boston, Massachusetts, United States